A Very-low-energy Fast Involves Increased Adipose Inflammatory Gene Expression: A 6-day Feeding Trial (FASTOMICS-6)
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf570 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Marianne Bråtveit und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Nutrition, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway. Hauptthemen laut MEDLINE: Obesity, Fasting, Subcutaneous Fat, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Haukeland University Hospital, University of Bergen, Western Norway Health Authority.
Abstract (Originalsprache)
Background
Fasting and ketogenic diets may have health benefits, but we lack a deeper understanding of tissue mechanisms and associated metabolome changes, particularly in humans.
Objective
Determine changes in subcutaneous adipose tissue (SAT) gene expression, plasma metabolomics, and circulating serum markers after a 6-day very-low-energy fast.
Methods
13 patients with obesity (mean body mass index = 41.6) underwent a week-long in-hospital feeding study (600 kcal/day). Body composition was assessed by bioimpedance. Blood and SAT were collected on days 1 and 7 for metabolomics (gas chromatography coupled with tandem mass spectrometry) and transcriptomics (RNA-sequencing). Biological pathways were inferred from affected gene sets (gene set enrichment analysis) and gene networks that correlated with plasma metabolites.
Results
Relative mean change (95% CI) in fat mass and fat-free mass was -2.07% (-2.93 to -1.20) and -4.42% (-5.53 to -3.28), respectively. Marked significant changes (relative mean change [95% CI]) were observed in total ketone bodies (acetoacetate + β-hydroxybutyrate) (+615% [366-999]), fasting insulin (-41.2% [-53.1 to -26.4]) and homeostatic model assessment for insulin resistance (-31.8% [-41.4 to -20.6]), as well as α-hydroxybutyrate (+103% [69.9-142]) and the advanced glycation end-products carboxyethyl-lysine (-46.0% [-53.6 to -37.2]) and carboxymethyl-lysine (-50.9% [-59.8 to -40.1]). Gene set enrichment analysis indicated upregulated inflammatory responses, and downregulated oxidative phosphorylation, adipogenesis, fatty acid metabolism, and mTORC1 signaling (P < .01) in SAT.
Conclusion
After a 6-day very-low-energy fast, adipose inflammatory gene expression increased concomitant with decreased plasma advanced glycation end-products and improved insulin sensitivity. These data suggest a role for inflammatory and autophagy-associated pathways in the metabolic adaptation to a ketogenic very-low-energy fast. Clinical Trial Registry number NCT02671279 (https://clinicaltrials.gov/study/NCT02671279)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Nutrition, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.
- Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, 5021 Bergen, Norway.
- Bevital AS, 5068 Bergen, Norway.
- Department of Research and Innovation, Haugesund Hospital, 5528 Haugesund, Norway.
- Department of Gastrointestinal Surgery, Haugesund Hospital, 5528 Haugesund, Norway.
- Deparment of Immunology and Transfusion Medicine, Haukeland University Hospital, 5021 Bergen, Norway.
ORCID-Profile: Marianne Bråtveit, Pouda P Strømland, Johnny Laupsa-Borge, Silje Kvistad, Elinor C Vogt, Adrian McCann, Andreas P Diamantopoulos, Bjørn Gunnar Nedrebø, Gunnar Mellgren, Simon N Dankel
Förderung
- Haukeland University Hospital
- University of Bergen
- Western Norway Health Authority
Zitieren
APA
Bråtveit, M., Strømland, P. P., Laupsa-Borge, J., Skumsnes, L., Dagsland, V. H., Kvistad, S., Vogt, E. C., McCann, A., Thorsen, H. L., Diamantopoulos, A. P., Nedrebø, B. G., Mellgren, G., & Dankel, S. N. (2025). A Very-low-energy Fast Involves Increased Adipose Inflammatory Gene Expression: A 6-day Feeding Trial (FASTOMICS-6). The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf570
Vancouver
Bråtveit M, Strømland PP, Laupsa-Borge J, Skumsnes L, Dagsland VH, Kvistad S, et al. A Very-low-energy Fast Involves Increased Adipose Inflammatory Gene Expression: A 6-day Feeding Trial (FASTOMICS-6). The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf570
BibTeX
@article{Brtveit2025,
author = {Bråtveit, Marianne and Strømland, Pouda P and Laupsa-Borge, Johnny and Skumsnes, Lillian and Dagsland, Vigdis H and Kvistad, Silje and Vogt, Elinor C and McCann, Adrian and Thorsen, Håvard L and Diamantopoulos, Andreas P and Nedrebø, Bjørn Gunnar and Mellgren, Gunnar and Dankel, Simon N},
title = {A Very-low-energy Fast Involves Increased Adipose Inflammatory Gene Expression: A 6-day Feeding Trial (FASTOMICS-6)},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf570}
}
EUVIMED